Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia (Q40831494)

24 September 2017

Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia (English)

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

27 March 2023

0 references

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

27 March 2023

author name string

B. Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

J. F. Holland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

O. Glidewell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

C. Jacquillat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

M. Weil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

C. Pochedly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

L. Sinks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

L. Chevalier

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

H. M. Maurer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

K. Koch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

G. Falkson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

R. Patterson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

B. Seligman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

J. Sartorius

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

F. Kung

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

F. Haurani

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

M. Stuart

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

E. O. Burgert

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

F. Ruymann

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

A. Sawitsky

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

E. Forman

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

H. Pluess

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

J. Truman

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

N. Hakami

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A337095

27 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=337095

27 March 2023

publication date

1 January 1977

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmpo.2950030410

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

https://onlinelibrary.wiley.com/doi/full/10.1002/mpo.2950030410

27 March 2023

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

27 March 2023

published in

Pediatric Blood Cancer

1 reference

Medical and Pediatric Oncology

24 September 2017

3

4

387–400

1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=337095

27 March 2023

volume

3

1 reference

24 September 2017

4

1 reference

24 September 2017

387-400

1 reference

Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia

24 September 2017

3

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

27 March 2023

4

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group

27 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Cancer chemotherapy reports

27 March 2023

8

54

47

Leventhal

1970

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Therapy of acute leukemia with drug combinations which include asparaginase

27 March 2023

9

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Corticosteroid Administration and Localized Leukocyte Mobilization in Man

27 March 2023

14

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Toxicity of E. coli L-asparaginase in man

27 March 2023

21

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Effect of L-asparaginase on carbohydrate metabolism

27 March 2023

22

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Toxicity of L-asparaginase in children with advanced leukemia

27 March 2023

23

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

L-Asparaginase and L-Asparagine Metabolism

27 March 2023

25

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

27 March 2023

L-asparaginase

28

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Duration and severity of fatty metamorphosis of the liver following L-asparaginase therapy

27 March 2023

29

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Cancer chemotherapy reports

27 March 2023

30

56

781

Falletta

1972

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

Latent onset of clinical pancreatitis in children receiving l-asparaginase therapy

27 March 2023

31

1 reference

https://api.crossref.org/works/10.1002/MPO.2950030410

27 March 2023

Identifiers

1 reference

24 September 2017

1 reference